Main menu

Identification of viral contamination of a biopharmaceutical product using nanopore sequencing


Contamination events in cell culture-derived biopharmaceuticals are very rare due to the implementation of strict testing procedures for the characterization of cell banks. However, they occurred regularly over the last decades and some of the more famous events included the detection of porcine circovirus in a rotavirus vaccine and simian virus 40 found in a poliovirus vaccine. This talk will describe the detection of contamination in a cell culture-derived biopharmaceutical observed at ViruSure. This contamination event was discovered using a cell-based in vitro adventitious agent testing approach, which is highly sensitive for the detection of virus present in underlying samples but is unable to identify the virus. Therefore, this sample was subjected to nanopore sequencing, which, after optimization of the sample preparation protocol, led to the identification of the contaminant as the epizootic haemorrhagic disease virus.

Authors: Hans-Peter Fasching

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

ナノポア技術

ナノポアの最新ニュースを購読 リソースと発表文献 Nanopore Communityとは

Oxford Nanoporeについて

ニュース 会社沿革 持続可能性 経営陣 メディアリソース & お問い合わせ先 投資家向け パートナー向け Oxford Nanopore社で働く 現在の募集状況 営業上の情報 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag